Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/20720558

Download in:

View as

General Info

PMID
20720558